Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Goldenberg

Showing results (251-260 of 1,192) with videos related to

Pageof 120
Sort By:
Journal of Medicinal Chemistry|November 1, 1975
2-(3,4-Dichloroanilino)quinolizinium bromide, a unique antispasmodic, antisecretory, and antiulcerogenic agentR J Alaimo, M M Goldenberg
Journal of Pharmaceutical Sciences|August 1, 1978
Synthesis and antiulcerogenic evaluation of 2-(substituted phenylimino)-2H-quinolizinesR J Alaimo, M M Goldenberg
Journal of Computer Assisted Tomography|August 1, 1984
Nonspecificity of intraparenchymal blood-fluid levels in cerebral computed tomographyS Spiegel, N Just, M Goldenberg
Gastroenterology|May 1, 1983
Carcinoembryonic antigen radioimmunodetection in colorectal cancerD M Goldenberg, F H Deland
Cancer Research|August 1, 1980
Immunological considerations in the use of goat antibodies to carcinoembryonic antigen for the radioimmunodetection of cancerF J Primus, D M Goldenberg
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2008
Therapy of human carcinoma xenografts with antibodies to EGFr and HER-2 conjugated to radionuclides emitting low-energy electronsM Jules Mattes, David M Goldenberg
Current Opinion in Investigational Drugs (London, England : 2000)|November 28, 2008
Novel radioimmunopharmaceuticals for cancer imaging and therapyRobert M Sharkey, David M Goldenberg
Clinical Cardiology|October 1, 1988
Quinine overdose: review of toxicity and treatmentA M Goldenberg, L F Wexler
NMR in Biomedicine|June 26, 2018
Assessments of tumor metabolism with CEST MRIJoshua M Goldenberg, Mark D Pagel
Expert Opinion on Biological Therapy|April 18, 2020
Sacituzumab govitecan, a novel, third-generation, antibody-drug conjugate (ADC) for cancer therapyDavid M Goldenberg, Robert M Sharkey
Pageof 120

Showing results (251-260 of 1,192) with videos related to

Sort By:
Pageof 120
Journal of Medicinal Chemistry|November 1, 1975
2-(3,4-Dichloroanilino)quinolizinium bromide, a unique antispasmodic, antisecretory, and antiulcerogenic agentR J Alaimo, M M Goldenberg
Journal of Pharmaceutical Sciences|August 1, 1978
Synthesis and antiulcerogenic evaluation of 2-(substituted phenylimino)-2H-quinolizinesR J Alaimo, M M Goldenberg
Journal of Computer Assisted Tomography|August 1, 1984
Nonspecificity of intraparenchymal blood-fluid levels in cerebral computed tomographyS Spiegel, N Just, M Goldenberg
Gastroenterology|May 1, 1983
Carcinoembryonic antigen radioimmunodetection in colorectal cancerD M Goldenberg, F H Deland
Cancer Research|August 1, 1980
Immunological considerations in the use of goat antibodies to carcinoembryonic antigen for the radioimmunodetection of cancerF J Primus, D M Goldenberg
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2008
Therapy of human carcinoma xenografts with antibodies to EGFr and HER-2 conjugated to radionuclides emitting low-energy electronsM Jules Mattes, David M Goldenberg
Current Opinion in Investigational Drugs (London, England : 2000)|November 28, 2008
Novel radioimmunopharmaceuticals for cancer imaging and therapyRobert M Sharkey, David M Goldenberg
Clinical Cardiology|October 1, 1988
Quinine overdose: review of toxicity and treatmentA M Goldenberg, L F Wexler
NMR in Biomedicine|June 26, 2018
Assessments of tumor metabolism with CEST MRIJoshua M Goldenberg, Mark D Pagel
Expert Opinion on Biological Therapy|April 18, 2020
Sacituzumab govitecan, a novel, third-generation, antibody-drug conjugate (ADC) for cancer therapyDavid M Goldenberg, Robert M Sharkey
Pageof 120